Takao Kimura

Dr. Takao Kimura

Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WSwenxin song
wenxin song
ABAnne P. Beigneux
Anne P. Beigneux
AWAnne-Marie Lund Winther
Anne-Marie Lund Winther
KKKristian Kristensen
Kristian Kristensen
AGAnne L. Grønnemose
Anne L. Grønnemose
SYStephen G. Young
Stephen G. Young
GPIHBP1, an endothelial cell (EC) protein, captures lipoprotein lipase (LPL) within the interstitial spaces (where it is secreted by myocytes and adipocytes) and transports it across ECs to its site of action in the capillary lumen. GPIHBP1’s 3-fingered LU domain is required for LPL binding, but the function of its acidic domain (AD) has remained unclear. We created mutant mice lacking the AD and found severe hypertriglyceridemia. As expected, the mutant GPIHBP1 retained the capacity to bind LPL. Unexpectedly, however, most of the GPIHBP1 and LPL in the mutant mice was located on the abluminal surface of ECs (explaining the hypertriglyceridemia). The GPIHBP1-bound LPL was trapped on the abluminal surface of ECs by electrostatic interactions between the large basic patch on the surface of LPL and negatively charged heparan sulfate proteoglycans (HSPGs) on the surface of ECs. GPIHBP1 trafficking across ECs in the mutant mice was normalized by disrupting LPL-HSPG electrostatic interactions with either heparin or an AD peptide. Thus, GPIHBP1’s AD plays a crucial function in plasma triglyceride metabolism; it sheathes LPL’s basic patch on the abluminal surface of ECs, thereby preventing LPL-HSPG interactions and freeing GPIHBP1-LPL complexes to move across ECs to the capillary lumen.

26 February 2016 in Journal of International Medical Research
Verified
Journal Article
Open access
KYKensuke Yoshida
Kensuke Yoshida
TKTakao Kimura
Takao Kimura
TATomoyuki Aoki
Tomoyuki Aoki
KTKatsuhiko Tsunekawa
Katsuhiko Tsunekawa
OAOsamu Araki
Osamu Araki
MMMasami Murakami
Masami Murakami
Objectives: To evaluate fasting serum insulin levels and insulin resistance, and their association with blood rheology, in Japanese young adults without diabetes. Methods: Blood samples were analysed and blood rheology was estimated using haematological parameters. Whole blood passage time was measured using a Hitachi MC-FAN© microchannel array flow analyser. Results: Out of 151 subjects (mean age, 24.1 ± 1.5 years), fasting serum insulin levels and insulin resistance (using homeostasis model assessment-estimated insulin resistance [HOMA-IR]), were positively correlated with longer whole blood passage times and higher values for haematocrit (Hct), haemoglobin (Hb), fibrinogen, body weight, body mass index (BMI), triglycerides, and low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio, and were negatively correlated with HDL-C. Whole blood passage time correlated with body weight, BMI, LDL-C/HDL-C ratio, Hct, Hb, white blood cell (WBC) count, platelet count, fibrinogen, fasting serum insulin levels, and HOMA-IR. Multiple regression analysis revealed that whole blood passage time was independently associated with Hct, fibrinogen levels, and WBC count. Conclusions: Fasting serum insulin levels and insulin resistance were associated with blood rheology, and may influence blood rheology by modulating haematological parameters and lipid parameters in young adults without diabetes.

25 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
TNTakumi Nagasawa
Takumi Nagasawa
TKTakao Kimura
Takao Kimura
AYAkihiro Yoshida
Akihiro Yoshida
KTKatsuhiko Tsunekawa
Katsuhiko Tsunekawa
OAOsamu Araki
Osamu Araki
MMMasami Murakami
Masami Murakami
In a recent study, we showed that konjac glucomannan (KGM) inhibits rice gruel-induced postprandial increases in plasma glucose and insulin levels. To extend this research, we investigated the effects of KGM addition to rice gruel on pre- and postprandial concentrations of circulating lipoprotein lipase (LPL), glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), hepatic triglyceride lipase (HTGL), free fatty acids (FFA), and triglycerides (TG). A total of 13 Japanese men, without diabetes, dyslipidemia, or gastrointestinal diseases, interchangeably ingested rice gruel containing no KGM (0%G), rice gruel supplemented with 0.4% KGM (0.4%G), and rice gruel supplemented with 0.8% KGM (0.8%G), every Sunday for 3 weeks. Blood samples were obtained at baseline and at 30, 60, and 120 min after ingestion to measure the abovementioned lipid parameters. Lipid parameters showed small, but significant, changes. Significant reductions were found in circulating FFA levels among all participants. Circulating TG levels significantly declined at 30 min and then remained nearly constant in the 0.8%G group but exhibited no significant difference in the 0%G and 0.4%G groups. Although circulating levels of LPL and GPIHBP1 significantly decreased in the 0%G and 0.4%G groups, they increased at 120 min in the 0.8%G group. Participants in the 0%G and 0.4%G groups showed significant decreases in circulating HTGL levels, which was not observed in the 0.8%G group. Our results demonstrate the novel pleiotropic effects of KGM. Supplementation of rice gruel with KGM powder led to TG reduction accompanied by LPL and GPIHBP1 elevation and HTGL stabilization, thereby attenuating TG metabolism.

1 July 2023 in Journal of Laboratory and Precision Medicine
Verified
Journal Article
Open access
PDF file
TKTakao Kimura
Takao Kimura
KTKatsuhiko Tsunekawa
Katsuhiko Tsunekawa
TNTakumi Nagasawa
Takumi Nagasawa
TATomoyuki Aoki
Tomoyuki Aoki
KMKazuya Miyashita
Kazuya Miyashita
MMMasami Murakami
Masami Murakami
Background and Objective: Despite optimal statin treatment, the risk of cardiovascular disease persists. Higher circulating triglyceride levels are linked to the development of cardiovascular disease. Clinical trials are currently being conducted to determine the efficacy of promoters of lipoprotein lipase (LPL) activity. However, the clinical significance of measuring plasma and serum LPL concentrations is unknown. Methods: The MEDLINE, EMBASE, PubMed, Web of Science, and Cochrane Central databases were scoured for English publications using the following keywords: triglyceride; lipoprotein lipase (LPL); glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1); chylomicron (CM); very low-density lipoprotein (VLDL); heparin; noncommunicable disease; insulin resistance; diabetes mellitus; pre-diabetes; cardiovascular disease; diagnosis; and prognosis. Key Content and Findings: LPL activity is highly regulated at the transcriptional, post-transcriptional, translational, and post-translational levels. The circulating levels of LPL show a negative relationship with triglycerides and HbA1c and a positive relationship with high-density lipoprotein (HDL) cholesterol and adiponectin. Circulating LPL levels are significantly reduced in arteriosclerotic diseases such as metabolic syndrome, diabetes, and cardiovascular diseases. The clinical significance of pre-heparin LPL measurement must be determined to assess the efficacy of triglyceride lowing drugs. Conclusions: Circulating LPL levels are linked to lipid parameters and are reduced in arteriosclerotic diseases; however, the regulatory mechanism of circulating LPL levels is unknown.

13 July 2020 in Annals of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
AYAkihiro Yoshida
Akihiro Yoshida
TKTakao Kimura
Takao Kimura
KTKatsuhiko Tsunekawa
Katsuhiko Tsunekawa
OAOsamu Araki
Osamu Araki
KUKazumi Ushiki
Kazumi Ushiki
MMMasami Murakami
Masami Murakami
Objective: Given the association between diabetes suppression and inhibition of diet-induced elevation in glucose and insulin, we investigated the effects of adding glucomannan to rice gruel on pre- and postprandial glucose and insulin concentrations. Methods: A total of 25 Japanese subjects without a history of diabetes or gastrointestinal disease (all males; aged 37–60 years; body mass index 20.4–31.6) participated in this study. Subjects received a 75-g oral glucose tolerance test (75gOGTT) and rice gruel containing 0, 0.4, or 0.8% of glucomannan. Blood samples were then obtained at preload and at 30, 60, and 120 min after receiving 75 g of glucose or rice gruel with or without glucomannan. Results: After the 75gOGTT, 8 subjects had normal glucose tolerance (NGT), whereas 17 showed a borderline pattern. Moreover, our data showed that greater amounts of glucomannan promoted lesser 30-min postload plasma glucose and insulin levels, with differences being larger in the borderline group than in the NGT group. Conclusions: Glucomannan dose-dependently inhibited the rice gruel-induced increase in 30-min postprandial plasma glucose and insulin levels. Furthermore, greater inhibitory effects on glucose and insulin elevation were observed in the borderline group than in the NGT group.

30 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
TNTakumi Nagasawa
Takumi Nagasawa
KSKoji Sakamaki
Koji Sakamaki
AYAkihiro Yoshida
Akihiro Yoshida
HMHIROKI MACHIDA
HIROKI MACHIDA
FMFumitaka Murakami
Fumitaka Murakami
TKTakao Kimura
Takao Kimura
Background/Objectives: This study aimed to identify the regulatory system of lipoprotein lipase (LPL), glycosylphosphatidylinositol-anchored high-density lipoprotein (HDL)-binding protein 1 (GPIHBP1), and hepatic triglyceride lipase (HTGL) in the peripheral bloodstream. Methods: In total, 207 individuals (100 males and 107 females) who were diagnosed with normal glucose tolerance or prediabetes during their comprehensive health checkup were investigated. Results: Circulating LPL levels were positively correlated with the GPIHBP1 and HDL-cholesterol (HDL-C) levels, and negatively correlated with body mass index (BMI), waist circumference (WC), Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) scores, triglyceride–glucose index, and triglyceride, fasting insulin, ferritin, and C-reactive protein (CRP) levels. The GPIHBP1 level was positively correlated with LPL and HTGL levels, and negatively correlated with estimated glomerular filtration rate (eGFR). The HTGL level was positively correlated with BMI, WC, HOMA-IR score, and GPIHBP1, low-density lipoprotein cholesterol (LDL-C), fasting insulin, and ferritin levels. Meanwhile, it was negatively correlated with HDL-C levels. The multiple regression analysis revealed that the circulating LPL level was independently affected by BMI, red blood cell (RBC) count, GPIHBP1, fasting plasma glucose (FPG), fasting insulin, HDL-C, CRP, and ferritin levels. The GPIHBP1 level was independently affected by age, eGFR, FPG, LPL, and HTGL levels and RBC count. The HTGL level was independently affected by WC, GPIHBP1 and LDL-C levels. Conclusions: LPL and HTGL levels reflect insulin resistance. In particular, individuals with a greater insulin resistance present with a lower LPL level and a higher HTGL level. An increased GPIHBP1 level might compensate for decreased LPL levels due to insulin resistance.